Allan Buzibye
Kampala, C, Uganda
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Once-Daily Dolutegravir-Based Antiretroviral Therapy Among Adults With Advanced HIV Disease Receiving 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis-Preventive Therapy and Fluconazole for Treatment of Cryptococcal Meningitis: Results of a Pharmacokinetic Study.
Journal: Open forum infectious diseases
Published: March 26, 2026
Mitochondrial DNA Patterns Among Individuals Living With HIV-1 on Dolutegravir With Hyperglycemia.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: February 02, 2026
Subtherapeutic exposure in doxorubicin pharmacokinetics among Ugandan breast cancer patients: a pilot study with implications for personalized therapy.
Journal: BMC research notes
Published: January 18, 2026
Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessment.
Journal: New microbes and new infections
Published: October 08, 2025
A High-Performance Liquid Chromatography-Mass Spectrometry method for simultaneous determination of dolutegravir, nevirapine, efavirenz, rifampicin and rifapentine concentrations in human plasma.
Journal: medRxiv : the preprint server for health sciences
Published: June 30, 2025
Therapeutic drug monitoring for antimicrobial agents for people living with HIV (TAP).
Journal: Wellcome open research
Published: April 15, 2025
Dolutegravir-associated hyperglycemia: a narrative review.
Journal: AIDS research and therapy
Published: March 13, 2025
A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda.
Journal: HIV medicine
Published: October 24, 2024
Pharmacokinetics of drugs used to treat drug sensitive-tuberculosis in breastfeeding mother-infant pairs: An observational pharmacokinetic study.
Journal: Wellcome open research
Published: July 05, 2024
Interim analysis, a tool to enhance efficiency of pharmacokinetic studies: Pharmacokinetics of rifampicin in lactating mother-infant pairs.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 20, 2024
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin.
Journal: Antimicrobial agents and chemotherapy
Published: October 18, 2023
Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin.
Journal: Antimicrobial agents and chemotherapy
Published: October 18, 2023
Last Updated: 09/26/2026